Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Wins SBIR Grant from NCI to Study Breast Cancer Networks

NEW YORK, Feb. 7 (GenomeWeb News) - GeneGo has won a Phase I Small Business Innovation Research grant from the National Cancer Institute to study cellular networks implicated in breast cancer, the St. Joseph, Mich.-based company said today.

 

GeneGo will use its MetaCore platform for mining high-throughput experimental data.

 

The amount of the grant was not immediately available from the company, but an NIH database listing grants for fiscal year 2005 includes a $99,880 award for GeneGo entitled "Elucidation of Protein Networks Implicated in BRCA."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.